39th AGM concluded: all 6 resolutions passed with requisite majority

Hester Biosciences held its 39th AGM on 21 July 2026 via video conferencing with 59 members attending. All 6 resolutions passed with requisite majority, including adoption of audited standalone and consolidated financial statements for FY ended 31 March 2026, declaration of dividend, reappointment of Mr. Sanjiv Gandhi as Director, ratification of Cost Auditor remuneration, and reappointment of Ms. Priya Gandhi as Executive Director. About 56.38% of paid-up equity capital participated through remote e-voting. All resolutions received over 99.67 percent votes in favor.